Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Examining aldosterone plasma concentration alterations post-ACTH stimulation in healthy subjects: a systematic literature review and meta-analysis on ACTH's role in aldosterone secretion.

Hormones (Athens, Greece)·2024
Same author

Contemporary reconstruction of a severe neuropathic foot burn injury.

Annals of burns and fire disasters·2020
Same author

Evaluation of the water quality status of two surface water reservoirs in a Mediterranean island.

Environmental monitoring and assessment·2018
Same author

Abdominal compartment syndrome (ACS) in a severely burned patient.

Annals of burns and fire disasters·2015
Same author

Outcomes of patients who commit suicide by burning.

Annals of burns and fire disasters·2013
Same author

Burns during Easter festivities in Greece.

Annals of burns and fire disasters·2013
Same journal

Isolated Deep Thermal Burns of the Dorsal Foot Treated by Excision and Split-Thickness Skin Grafting at the Burn Centre of Lille: Characteristics, Surgical Management and Healing Delay.

Annals of burns and fire disasters·2026
Same journal

Self-Esteem and Social Support: Predictors of Psychological Well-Being in Severe Burn Survivors.

Annals of burns and fire disasters·2026
Same journal

Efficacy of Collagen Dressing for Scald Burn Among the Paediatric Population.

Annals of burns and fire disasters·2026
Same journal

Annals of burns and fire disasters·2026
Same journal

Mortality Analysis of ICU Burn Patients in Indonesia's National Referral Hospital: A 2-Year Retrospective Study.

Annals of burns and fire disasters·2026
Same journal

Epidemiology and Risk Factors of Burn Injuries During the Cold Season in a Regional Hospital in Northeast Thailand: A Retrospective Study.

Annals of burns and fire disasters·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Stevens-johnson syndrome: a case report.

O Castana1, G Rempelos, G Anagiotos

  • 1Department of Plastic and Reconstructive Surgery, Evangelismos General Hospital, Athens, Greece.

Annals of Burns and Fire Disasters
|October 13, 2011
PubMed
Summary
This summary is machine-generated.

Stevens-Johnson syndrome mimics severe burns, causing total epidermis loss. Prompt recognition and burn care protocols, including fluid resuscitation, improve patient outcomes and reduce mortality.

Keywords:
CASE REPORTSTEVENS-JOHNSONSYNDROME

Related Experiment Videos

Last Updated: May 28, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

Area of Science:

  • Dermatology
  • Critical Care Medicine

Background:

  • Stevens-Johnson syndrome (SJS) presents with severe mucocutaneous reactions.
  • It can mimic a partial-thickness burn, leading to extensive epidermal loss.

Observation:

  • A 38-year-old male developed SJS after antiepileptic drug administration.
  • The patient exhibited total epidermal sloughing, high fever, and severe burn-like symptoms.

Findings:

  • The patient was managed using burn care protocols, including the Parkland formula for fluid resuscitation.
  • Initial steroid administration was followed by systemic antibiotics to manage sepsis and infection.

Implications:

  • Effective management of SJS requires prompt recognition and treatment similar to severe burn care.
  • Advances in critical burn care techniques can decrease mortality and morbidity associated with SJS.